HDAC4 and breast cancer: miRNA-22, miRNA-10b and miRNA-125a-5p was suggested to interact with HDAC4 and contributed an impact on the drug-resistance in breast cancer cells (Ahmad et al., 2015; Hsieh et al., 2015a; Wang et al., 2018).